Clinical Trials on Uveal Melanoma in South Africa
Total 350 results
-
Novartis PharmaceuticalsRecruitingMetastatic Uveal MelanomaUnited States, Australia, France, Netherlands, Switzerland, Germany, Spain
-
National Cancer Institute (NCI)ExelisisCompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal Melanoma | Stage III Uveal Melanoma AJCC v7 | Stage IIIA Uveal Melanoma AJCC v7 | Stage IIIB Uveal Melanoma AJCC v7 | Stage IIIC Uveal Melanoma AJCC v7United States, Canada
-
Novartis PharmaceuticalsTerminatedUveal MelanomaUnited States, Australia, France, Netherlands, Spain, Norway
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
National Cancer Institute (NCI)CompletedStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Mucosal Melanoma | Iris Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7 | Stage IV Uveal Melanoma AJCC v7 | Medium/Large Size Posterior Uveal Melanoma | Recurrent... and other conditionsUnited States
-
IDEAYA BiosciencesRecruitingMetastatic Uveal MelanomaUnited States, Canada, Israel, Spain, Australia, Germany, France, Italy, United Kingdom, Netherlands, Belgium, Poland, Switzerland
-
Aura BiosciencesCompletedOcular Melanoma | Uveal Melanoma | Choroidal MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Aura BiosciencesActive, not recruitingOcular Melanoma | Uveal Melanoma | Choroidal MelanomaUnited States
-
Immunocore LtdActive, not recruitingUveal MelanomaUnited States, Canada, United Kingdom, Spain, France, Germany, Poland, Australia, Belgium, Italy, Netherlands, Russian Federation, Switzerland, Ukraine
-
IDEAYA BiosciencesRecruitingUveal MelanomaUnited States, Netherlands, Australia, Canada, Italy, France, Germany, United Kingdom
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsUnited States, South Africa, Croatia, Brazil, Egypt
-
Aura BiosciencesRecruitingOcular Melanoma | Uveal Melanoma | Choroidal Melanoma | Indeterminate LesionsUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsRussian Federation, Korea, Republic of, Israel, South Africa, Belarus
-
Merck Sharp & Dohme LLCCompletedMelanomaAustralia, South Africa, Spain, Sweden
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCNot yet recruitingMucosal MelanomaAustralia
-
Evaxion Biotech A/SNovotech (Australia) Pty LimitedTerminatedMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
Anthony Joshua, FRACPSt Vincent's Hospital, SydneyActive, not recruiting
-
Evaxion Biotech A/SMerck Sharp & Dohme LLCRecruitingMelanoma Stage IV | Melanoma Stage IIIAustralia
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIAustria, Netherlands, Australia, Sweden
-
Immutep Australia Pty. Ltd.CompletedStage IV Melanoma | Stage III MelanomaAustralia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
University of SydneyMelanoma and Skin Cancer Trials LimitedCompleted
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruitingMelanoma Stage IvAustralia, Norway
-
IO BiotechMerck Sharp & Dohme LLC; Syneos HealthActive, not recruitingMetastatic Melanoma | Unresectable MelanomaHungary, Spain, United Kingdom, Australia, France, Italy, United States, Denmark, Germany, Israel, Czechia, Belgium, Netherlands, Turkey, Poland, South Africa
-
Melanoma and Skin Cancer Trials LimitedBristol-Myers Squibb; Amgen; Peter MacCallum Cancer Centre, AustraliaActive, not recruitingMelanoma | Melanoma Stage Iv | Melanoma Stage IiiAustralia
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
Ascentage Pharma Group Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | P53 Mutation | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Malignant Peripheral Nerve Sheath Tumors | MPNST | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | MDM2 Gene MutationUnited States, Australia
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Myrexis Inc.Completed
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Lipotek Pty LtdRoyal Adelaide Hospital; Trident Clinical Research Pty LtdCompleted
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Trans Tasman Radiation Oncology GroupUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...CompletedLymph Node Disease | Malignant MelanomaAustralia, New Zealand, Netherlands, Brazil
-
Genentech, Inc.CompletedMalignant MelanomaUnited States, Australia
-
Prisma Health-UpstateOncolix, Inc.Terminated
-
Medical University of South CarolinaTerminated
-
Aura BiosciencesTerminatedChoroidal Melanoma | Indeterminate LesionsUnited States
-
AbbottBiogenTerminated
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
Melanoma Institute AustraliaNovartisRecruiting
-
Immunocore LtdRecruitingAdvanced MelanomaUnited States, Australia
-
Melanoma Institute AustraliaWithdrawnMelanoma | In-Transit Metastasis of Cutaneous MelanomaAustralia
-
QBiotics Group LimitedMerck Sharp & Dohme LLCTerminated
-
CancerVax CorporationUnknownMelanoma (Skin)United States, Australia